Subscribe To
Allergy therapeutics posts improved results from hay fever study
Allergy Therapeutics PLC (AIM:AGY) has presented new data showing the use of its grass pollen vaccine can cut hay fever symptoms by around 40%. Poster...
March 1, 2022, 5:20 am
Allergy therapeutics posts improved results from hay fever study
Allergy Therapeutics PLC (AIM:AGY) has presented new data showing the use of its grass pollen vaccine can cut hay fever symptoms by around 40%. Poster...
March 1, 2022, 5:20 am
Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments
If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so. Fresh from a US$31.25 million fundraise and...
February 23, 2022, 6:31 am
Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments
If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so. Fresh from a US$31.25 million fundraise and...
February 23, 2022, 6:31 am
Context therapeutics prepares for a busy 2022 as it advances women's oncology treatments
If 2021 was a pivotal year for Context Therapeutics (NASDAQ:CNTX) Inc, 2022 promises to be even more so. Fresh from a US$31.25 million fundraise and...
February 23, 2022, 6:31 am
Biontech, medigene ink immunotherapy pact against cancer
BioNTech SE (NASDAQ: BNTX) and Medigene AG have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapie...
February 22, 2022, 7:31 am
Biontech, medigene ink immunotherapy pact against cancer
BioNTech SE (NASDAQ: BNTX) and Medigene AG have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapie...
February 22, 2022, 7:31 am
Biontech, medigene ink immunotherapy pact against cancer
BioNTech SE (NASDAQ: BNTX) and Medigene AG have entered a multi-target research collaboration to develop T cell receptor (TCR) based immunotherapie...
February 22, 2022, 7:31 am
Alkermes' nemvaleukin shows encouraging anti-tumor activity in pretreated kidney cancer
Alkermes plc (NASDAQ: ALKS) presented new data from the ongoing phase 1/2 ARTISTRY-1 trial for nemvaleukin alfa, engineered interleukin-2 (IL-2) va...
February 17, 2022, 11:23 am
Alkermes' nemvaleukin shows encouraging anti-tumor activity in pretreated kidney cancer
Alkermes plc (NASDAQ: ALKS) presented new data from the ongoing phase 1/2 ARTISTRY-1 trial for nemvaleukin alfa, engineered interleukin-2 (IL-2) va...
February 17, 2022, 11:23 am
Alkermes' nemvaleukin shows encouraging anti-tumor activity in pretreated kidney cancer
Alkermes plc (NASDAQ: ALKS) presented new data from the ongoing phase 1/2 ARTISTRY-1 trial for nemvaleukin alfa, engineered interleukin-2 (IL-2) va...
February 17, 2022, 11:23 am
Hookipa pharma stock surges on hiv pact with gilead
Hookipa Pharma Inc (NASDAQ: HOOK) amended and restated collaboration and license agreement with Gilead Sciences Inc (NASDAQ: GILD) for arenaviral...
February 16, 2022, 8:17 am
Hookipa pharma stock surges on hiv pact with gilead
Hookipa Pharma Inc (NASDAQ: HOOK) amended and restated collaboration and license agreement with Gilead Sciences Inc (NASDAQ: GILD) for arenaviral...
February 16, 2022, 8:17 am
Hookipa pharma stock surges on hiv pact with gilead
Hookipa Pharma Inc (NASDAQ: HOOK) amended and restated collaboration and license agreement with Gilead Sciences Inc (NASDAQ: GILD) for arenaviral...
February 16, 2022, 8:17 am
Fda clears cidara therapeutics' phase 1 trial for immunotherapeutic antiviral for influenza
The FDA has signed off Cidara Therapeutics Inc's (NASDAQ: CDTX) Investigational New Drug (IND) application for its lead flu drug-Fc conjugate (DFC),...
February 14, 2022, 10:12 am
Fda clears cidara therapeutics' phase 1 trial for immunotherapeutic antiviral for influenza
The FDA has signed off Cidara Therapeutics Inc's (NASDAQ: CDTX) Investigational New Drug (IND) application for its lead flu drug-Fc conjugate (DFC),...
February 14, 2022, 10:12 am
Fda clears cidara therapeutics' phase 1 trial for immunotherapeutic antiviral for influenza
The FDA has signed off Cidara Therapeutics Inc's (NASDAQ: CDTX) Investigational New Drug (IND) application for its lead flu drug-Fc conjugate (DFC),...
February 14, 2022, 10:12 am
Week in review: u.s. fda rejects innovent/lilly pd-1 nda based on china-only trial subjects
A US FDA oncology advisory panel rejected the NDA submitted by Innovent and Lilly for their partnered anti-PD-1 antibody, voting 14-1 against approval...
February 13, 2022, 10:35 pm
Week in review: u.s. fda rejects innovent/lilly pd-1 nda based on china-only trial subjects
A US FDA oncology advisory panel rejected the NDA submitted by Innovent and Lilly for their partnered anti-PD-1 antibody, voting 14-1 against approval...
February 13, 2022, 10:35 pm
Week in review: u.s. fda rejects innovent/lilly pd-1 nda based on china-only trial subjects
A US FDA oncology advisory panel rejected the NDA submitted by Innovent and Lilly for their partnered anti-PD-1 antibody, voting 14-1 against approval...
February 13, 2022, 10:35 pm